STAB — Statera Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Statera Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8.79	4.12	1.58	2.27	1.98
Net Total Accounts Receivable
Net Total Receivables	0.554	0.252	0.379	0.012	0.349
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9.58	4.48	2	2.31	4.15
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.019	0.028	0.016	0.004	1.17
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	9.63	4.53	2.04	2.32	21.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.21	0.912	1.52	0.305	11.2
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	7.43	5.99	6.56	5.28	22.7
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2.2	-1.45	-4.52	-2.96	-1.57
Total Liabilities & Shareholders' Equity	9.63	4.53	2.04	2.32	21.2
Total Common Shares Outstanding
Total Preferred Shares Outstanding